| Bioactivity | [Ru(dppn)2phen](PF6)2 (compound 4) is a polypyridylruthenium compound used in photodynamic therapy (PDT). [Ru(dppn)2phen](PF6)2 is normally nontoxic under dark conditions and induces mitochondrial respiratory damage upon light exposure. [Ru(dppn)2phen](PF6)2 exhibits high levels of singlet oxygen quantum yield and phototoxicity against cancer cells[1]. |
| Name | [Ru(dppn)2phen](PF6)2 |
| Formula | C56H32F12N10P2Ru |
| Molar Mass | 1235.92 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pozza MD et al. Increasing the π-Expansive Ligands in Ruthenium(II) Polypyridyl Complexes: Synthesis, Characterization, and Biological Evaluation for Photodynamic Therapy Applications. Inorg Chem. 2023 Nov 13;62(45):18510-18523. |
[Ru(dppn)2phen](PF6)2
CAS: F: C56H32F12N10P2Ru W: 1235.92
(PF6)2 (compound 4) is a polypyridylruthenium compound used in photodynamic therapy (PDT). (PF6)2 is normally nontoxic u
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.